CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 59 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,578 | -53.6% | 79,745 | -18.6% | 0.00% | – |
| Q2 2023 | $117,626 | – | 98,022 | +112569.0% | 0.00% | – |
| Q1 2023 | $0 | – | 87 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 87 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 87 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 87 | -99.9% | 0.00% | – |
| Q1 2022 | $104,000 | +55.2% | 58,192 | +33.3% | 0.00% | – |
| Q4 2021 | $67,000 | -63.0% | 43,670 | -51.1% | 0.00% | – |
| Q3 2021 | $181,000 | -66.2% | 89,372 | -41.8% | 0.00% | – |
| Q2 2021 | $535,000 | – | 153,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 196,867 | $181,000 | 0.05% |
| Wealth Advisory Solutions, LLC | 156,850 | $144,000 | 0.04% |
| Horst & Graben Wealth Management LLC | 75,722 | $70,000 | 0.02% |
| Ergoteles LLC | 451,890 | $416,000 | 0.01% |
| Miller Investment Management, LP | 50,000 | $46,000 | 0.01% |
| Virtu Financial LLC | 81,410 | $75,000 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 17,342 | $16,000 | 0.00% |
| Kestra Advisory Services, LLC | 71,102 | $65,000 | 0.00% |
| Csenge Advisory Group | 15,000 | $14,000 | 0.00% |
| Qube Research & Technologies Ltd | 121,281 | $112,000 | 0.00% |